Cerus (CERS) EBITDA Margin Growth (3y) (2013 - 2026)
Cerus (CERS) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.55 Bn | 196.95 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 126.43 Bn | 122.95 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 74.11 Bn | 73.57 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.70 Bn | 47.44 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 35.04 Bn | 33.10 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.73 Bn | 31.62 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 244.00 |
| 10 | Cerus | 563.59 Mn | 507.32 Mn | 29.53 Mn | -5,815.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,672.00 |
| Mar 31, 2026 | 10,018.00 |
| Dec 31, 2025 | 484.00 |
| Sep 30, 2025 | 12,636.00 |
| Jun 30, 2025 | -60,911.00 |
| Mar 31, 2025 | 5,300.00 |
| Dec 31, 2024 | 407.00 |
| Sep 30, 2024 | 4,829.00 |
| Jun 30, 2024 | 8,558.00 |
| Mar 31, 2024 | 14,939.00 |
| Dec 31, 2023 | 1,590.00 |
| Sep 30, 2023 | -72,250.00 |
| Jun 30, 2023 | 7,105.00 |
| Mar 31, 2023 | 480,425.00 |
| Dec 31, 2022 | 28,919.00 |
| Sep 30, 2022 | 391,806.00 |
| Jun 30, 2022 | 37,698.00 |
| Mar 31, 2022 | 28,653.00 |
| Dec 31, 2021 | 8,745.00 |
| Sep 30, 2021 | -9,802.00 |